Instead of just masking allergy symptoms with antihistamines, scientists are now targeting the root cause by studying the precise protein structures that trigger allergic reactions. A biochemist at Michigan State University is leading one of the few labs in the country using advanced molecular analysis to understand why our immune systems mistakenly attack harmless substances like pollen, peanuts, and dust mites. This approach could eventually lead to personalized allergy treatments tailored to each person's specific triggers.

What Makes a Protein an Allergen?

For one in three Americans living with allergies, the current approach feels limited. You take an antihistamine, avoid certain foods, and hope for the best. But biochemist Maksymilian Chruszcz at Michigan State University sees a fundamental problem with this strategy.

"When it comes to allergies, we're often told, 'Take an antihistamine,' but that's not solving anything. Instead of treating the symptoms, we'd like to treat the disease," said Chruszcz.

Maksymilian Chruszcz, WF Patenge Chair in the Department of Biochemistry and Molecular Biology at Michigan State University

At the heart of Chruszcz's work is a fundamental question: what actually makes a protein an allergen? The answer lies in understanding how your immune system gets confused. When you're exposed to birch tree pollen, for example, your body's defense system mistakenly identifies it as a dangerous invader. In response, your immune system produces high-powered antibodies called immunoglobulin E, or IgE. These antibodies are normally designed to fight parasitic worms, not pollen. Once your body becomes "sensitized" to this threat, the next time you encounter birch pollen, those IgE antibodies trigger a cascade of inflammatory chemicals that cause itchy eyes, runny nose, and overall misery.

Using advanced analytical tools like X-ray crystallography, Chruszcz's team is defining the molecular properties of allergen proteins and mapping exactly how they interact with antibodies. This is no small task. Of the approximately 1,200 officially registered allergens, only a fraction have been characterized from a biochemical and structural point of view. The challenge is even broader: we encounter thousands of proteins in daily life, so researchers must determine what distinguishes an allergen from a harmless protein.

How Can Personalized Allergy Testing Change Your Diagnosis?

One of the most promising applications of this protein research is something called component-resolved diagnostics. Instead of relying on standard allergy tests that are often poorly standardized, this approach uses precise molecular characterization to identify the exact proteins causing an allergic reaction.

"We can discover very detailed interactions between molecules. We can not only tell a particular person they're sensitized to peanuts, but what two or three proteins are causing their condition. Going even further, we can find out the exact fragments of an allergen that are responsible for triggering an allergic reaction. In principle, we can create an antibody cocktail to provide personalized treatment," explained Chruszcz.

Maksymilian Chruszcz, WF Patenge Chair in the Department of Biochemistry and Molecular Biology at Michigan State University

This level of precision could transform allergy care. Rather than knowing only that you're allergic to peanuts, doctors could identify which specific peanut proteins trigger your reaction. This information could eventually enable targeted treatments designed specifically for your immune system's response.

Steps to Understanding Your Allergy Risk Better

While personalized allergy treatments are still in development, understanding the science behind allergies can help you recognize patterns in your own health. Here are key concepts that researchers are using to advance allergy care:

• Epitope Mapping: Scientists identify the precise locations on allergen proteins where antibodies bind and trigger immune responses. By understanding these binding sites, researchers can develop modified allergens with greatly reduced ability to trigger reactions.
• Hypoallergenic Immunotherapy: By mutating a handful of epitopes on allergen proteins, researchers hope to create hypoallergens that help your body build tolerance with minimal side effects and even prompt production of protective antibodies upon re-exposure.
• Cross-Reactivity Recognition: Understanding how proteins from different sources can trigger similar allergic reactions helps explain why someone allergic to birch pollen might also react to raw carrots, apples, or celery.
• Component-Resolved Diagnostics: This testing method identifies the specific protein fragments responsible for your allergic reaction, enabling doctors to create targeted treatment plans rather than one-size-fits-all approaches.

Why Pollen Allergies Can Trigger Food Allergies?

One of the most surprising discoveries from this protein research involves a condition called pollen-food allergy syndrome. Many adults with food allergies don't realize they have this condition, which occurs through a phenomenon called cross-reactivity. When your immune system produces antibodies to recognize pollen proteins, those same antibodies can mistakenly attack similar-looking molecules found in raw fruits and vegetables.

The reason is straightforward: pollen proteins are remarkably similar to those found in raw fruits and vegetables. Someone with a severe birch pollen allergy might develop an allergic reaction when eating carrots, apples, or celery. This cross-reactivity extends beyond pollen and produce. Researchers have discovered that shellfish allergies can develop from cross-reactivity with dust mite allergens, and crocodile meat proteins are strikingly similar to those in fish.

Chruszcz's lab is one of only two academic teams in the entire country working on this type of allergen protein research. The rarity of this work means the lab receives requests from researchers worldwide asking them to characterize mysterious protein allergens. This international collaboration is expanding our understanding of how allergies develop across different populations and food sources.

What's Next for Allergy Treatment?

For nearly two decades, Chruszcz has collaborated with biotechnology companies to develop immunotherapy treatments for dust mite allergies, which are thought to be key triggers of allergic asthma. These hypoallergen-based treatments represent a fundamentally different approach from current allergy medications. Rather than blocking histamine or suppressing symptoms, they aim to help your immune system build genuine tolerance to the allergen.

The field of allergen research continues to reveal surprising connections and mysteries. When researchers used CRISPR gene-editing technology to knock out the gene responsible for an allergen found in cat saliva, that gene appeared nonessential for overall feline health. This raises intriguing questions about why certain proteins trigger allergies in the first place.

As our world changes, new allergen challenges emerge. Global food trade means we're exposed to proteins from completely unfamiliar sources. Invasive plant species introduce new allergens to regions where they didn't previously exist. The rise in exotic pets creates exposure to allergens our ancestors never encountered. For Chruszcz and his team, this means an expanding frontier of mystery molecules to characterize and new opportunities to develop therapeutics that could one day reduce the sneezing, wheezing, and itchy eyes that affect millions of Americans.